Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The B-cell receptor idiotype refers to the unique antigenic determinants located in the variable regions of an individual B cell’s immunoglobulin/B-cell receptor; these idiotypic determinants (Ids) arise from somatic V(D)J recombination and define the clonotypic specificity of the BCR. The B-cell receptor itself is a membrane immunoglobulin (isotypes IgM/IgD/IgG/IgA/IgE) noncovalently associated with the Igα/Igβ (CD79A/CD79B) signaling heterodimer bearing ITAMs that initiate signaling upon antigen binding. Idiotypes are immunogenic and can elicit anti-idiotype immune responses; B cells can present idiotype-derived peptides via MHC class II to T cells, integrating idiotype/anti-idiotype interactions into immune regulation and memory. Clinically, the tumor-specific BCR idiotype of clonal B-cell malignancies has been exploited as a therapeutic target using anti-idiotype monoclonal antibodies and patient-specific idiotype vaccines, and as a sensitive biomarker for disease monitoring.
Direct binding and neutralization/depletion of B cells expressing the targeted idiotype by anti-idiotype antibodies (via opsonization, ADCC, CDC); Active immunization to elicit anti-idiotype immune responses that recognize and eliminate idiotype-expressing malignant B cells (idiotype vaccination); T cell–mediated responses induced by presentation of idiotype-derived peptides (MHC class II) following B-cell activation, supporting anti-idiotype immunity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B-cell receptor idiotype (Id (idiotype)).